These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11495558)

  • 1. Care of HIV-infected pregnant women in maternal-fetal medicine programs.
    Sklar PA; Bathgate SL; Young HA; Parenti DM
    Infect Dis Obstet Gynecol; 2001; 9(2):81-7. PubMed ID: 11495558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management and therapy of human immunodeficiency virus-infected pregnancies in maternal-fetal medicine fellowship training programs.
    Grossman JH; Nies BM; Lopez-Zeno J; Bathgate SL; Parenti DM
    Obstet Gynecol; 1992 Dec; 80(6):985-8. PubMed ID: 1448269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scheduled cesarean delivery and the prevention of human immunodeficiency virus transmission: a survey of practicing obstetricians.
    Rowland BL; Vermillion ST; Soper DE
    Am J Obstet Gynecol; 2001 Aug; 185(2):327-31. PubMed ID: 11518886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV infection and zidovudine use in childbearing women.
    Sia J; Paul S; Martin RM; Cross H
    Pediatrics; 2004 Dec; 114(6):e707-12. PubMed ID: 15545619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mother-to-child HIV transmission prevention in Thailand: physician zidovudine use and willingness to provide care.
    Bhatta MP; Stringer JS; Phanuphak P; Vermund SH
    Int J STD AIDS; 2003 Jun; 14(6):404-10. PubMed ID: 12816669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Obstetric and perinatal complications in HIV-infected women. Analysis of a cohort of 167 pregnancies between 1997 and 2003.
    Martí C; Peña JM; Bates I; Madero R; de José I; Pallardo LF; Arribas JR; Gonzalez-Garcia J; Gonzalez A; Vazquez JJ
    Acta Obstet Gynecol Scand; 2007; 86(4):409-15. PubMed ID: 17486461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Declines in low birth weight and preterm birth among infants who were born to HIV-infected women during an era of increased use of maternal antiretroviral drugs: Pediatric Spectrum of HIV Disease, 1989-2004.
    Schulte J; Dominguez K; Sukalac T; Bohannon B; Fowler MG;
    Pediatrics; 2007 Apr; 119(4):e900-6. PubMed ID: 17353299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.
    Read JS; Cahn P; Losso M; Pinto J; Joao E; Duarte G; Cardoso E; Freimanis-Hance L; Stoszek SK;
    Obstet Gynecol; 2007 Jun; 109(6):1358-67. PubMed ID: 17540808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. International recommendations on antiretroviral drugs for treatment of HIV-infected women and prevention of mother-to-child HIV transmission in resource-limited settings: 2006 update.
    Dao H; Mofenson LM; Ekpini R; Gilks CF; Barnhart M; Bolu O; Shaffer N
    Am J Obstet Gynecol; 2007 Sep; 197(3 Suppl):S42-55. PubMed ID: 17825650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Provision of care following prevention of mother-to-child HIV transmission services in resource-limited settings.
    Ginsburg AS; Hoblitzelle CW; Sripipatana TL; Wilfert CM
    AIDS; 2007 Nov; 21(18):2529-32. PubMed ID: 18025890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
    Palombi L; Marazzi MC; Voetberg A; Magid NA
    AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotypic resistance tests for the management of the HIV-infected pregnant woman.
    Bassetti D; Cargnel A
    Scand J Infect Dis Suppl; 2003; 106():70-4. PubMed ID: 15000589
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antiretroviral treatment during pregnancy.
    Keiser O; Gayet-Ageron A; Rudin C; Brinkhof MW; Gremlich E; Wunder D; Drack G; Hirschel B; de Tejada BM; ;
    AIDS; 2008 Nov; 22(17):2323-30. PubMed ID: 18981771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human immunodeficiency virus infection in pregnant women. The importance of recognizing the infection during pregnancy and risk factors for perinatal transmission].
    Ovalle A; Vizueta E; Casals A; Northland R; González R; Labbe E
    Rev Med Chil; 2003 Jun; 131(6):633-40. PubMed ID: 12942591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. German-Austrian recommendations for HIV-therapy in pregnancy--common declaration of The German AIDS-society (DAIG), The Austrian AIDS-society (OEAG) as well as The Robert-Koch Institute Berlin (RKI), The German Association of Physicians specialized in HIV Care (DAGNAE), The German Society of Pediatric and Youth Medicine (DGKJ), The German AIDS Pediatric Association (PAAD), The German Society of Obstetrics and Gynecology (DGGG), The National Reference Center for Retroviruses (NRZ), German AIDS Assistance (DAH).
    Buchholz B; Marcus U; Beichert M; Grubert T; Gingelmaier A; Kaestner R; Grosch-Woerner I; Brockmeyer NH; ; ; ; ; ; ; ; ;
    Eur J Med Res; 2002 Oct; 7(10):417-33. PubMed ID: 12435621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of HIV-1 infected pregnant women].
    Nellen JF; Godfried MH; Kreijenbroek ME; Scherpbier HJ; Prins JM; Boer K
    Ned Tijdschr Geneeskd; 2004 Oct; 148(41):2005-8. PubMed ID: 15553994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance among HIV-infected pregnant women receiving antiretrovirals for prophylaxis.
    Duran AS; Losso MH; Salomón H; Harris DR; Pampuro S; Soto-Ramirez LE; Duarte G; de Souza RS; Read JS;
    AIDS; 2007 Jan; 21(2):199-205. PubMed ID: 17197811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adverse effects of antiretrovirals in HIV-infected pregnant women.
    Zuk DM; Hughes CA; Foisy MM; Robinson JL; Singh AE; Houston S
    Ann Pharmacother; 2009 Jun; 43(6):1028-35. PubMed ID: 19491318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Highly active antiretroviral therapy (HAART) in HIV-positive pregnant women in the Netherlands, 1997-2003: safe, effective and with few side effects].
    Tempelman C; Timmermans S; Godfried MH; Dieleman JP; Boer K; van der Ende ME
    Ned Tijdschr Geneeskd; 2004 Oct; 148(41):2021-5. PubMed ID: 15553999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.